
51 - 200 employees
Founded 2016
💰 $205M Post-IPO Equity on 2022-06
Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Our most advanced investigational product candidate, apitegromab (SRK-015), a
🕒 June 24
51 - 200
Sr. Medical Science Liaison developing relationships with KOLs and delivering scientific presentations. Supporting clinical development for SMA treatments in a remote environment.
🇺🇸 United States – Remote
💵 $220k - $250k / year
💰 $205M Post-IPO Equity on 2022-06
⏰ Full Time
🟠 Senior
🕒 June 16
51 - 200
Lead the strategic direction and operations within the US region for Scholar Rock's apitegromab. Build cross-functional teams and direct the launch of the first muscle-targeted treatment for SMA.
🇺🇸 United States – Remote
💵 $265k - $300k / year
💰 $205M Post-IPO Equity on 2022-06
⏰ Full Time
🟠 Senior
🔴 Lead
👔 Manager
🕒 June 8
51 - 200
HR Business Partner providing strategic HR leadership for biopharmaceutical global operations. Advising on talent acquisition, employee relations, and organizational development.
🍂 Massachusetts – Remote
💵 $265k - $300k / year
💰 $205M Post-IPO Equity on 2022-06
⏰ Full Time
🟠 Senior
👩👩👧👦 Human Resources (HR)